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The key factors governing the absorption of drugs from
the lungs are deposition pattern, dissolution rate, solubility
and permeability. Whereas the thin epithelium in the
respiratory airways is generally considered to constitute a
minor barrier in the overall absorption process, the other
two components depend, among other parameters, on the
formulation and the particle size. This is of particular
importance for compounds with very low solubility.
The aim of this work was to evaluate strategies to
improve the rate and extent of lung absorption in rats
which were administered with suspensions of low-solubility
compound by the intratracheal route. The two approaches
evaluated were (a) the reduction of the particle size by
micronization to increase the total surface area and hence
to speed up the dissolution, and (b) the addition of methyl-
cellulose to the vehicle, thereby enhancing its viscosity and
potentially increasing the compound solubility.
For the pharmacokinetic studies performed with male
Wistar rats, the test compounds were formulated in PBS
(pH 7.4)/0.2 % Tween-80 with or without the addition of
0.3 % methylcellulose (Sigma-Aldrich M0512, 4000 cPs).
Compounds were used either directly as obtained from the
chemical synthesis or after a micronization process. Sus-
pensions were delivered into the respiratory tract of the
rats using a Penn-Century liquid microsprayer (200 uL).
Disappearance of the compounds from the target organ
within a 24-h period post-dose was monitored by UPLC-
ESI-MS/MS.
The pharmacokinetic data obtained for chemically
diverse compounds indicated that both strategies affected
in a very distinct, compound-dependent fashion the pul-
monary absorption. In conclusion, micronization and, if
this is not technically feasible, addition of methylcellulose
to the vehicle may constitute a suitable means of enhan-
cing the pulmonary absorption of compounds delivered
into airways of rats. Based on the presented findings, pre-
dicting the effect of either methodology appears to be dif-
ficult and thus requires a case-by-case evaluation.
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